Antiphospholipid Antibodies Linked to Future CV Events
The study raises the possibility of one day treating the immune system in some individuals for the prevention and treatment of cardiovascular disease, researchers suggest.
Source: medscape.com
Page 4 - Platelet Count News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Platelet Count. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Platelet Count Today - Breaking & Trending Today
Biomarkers for Treatment Response Evaluated in Children With CSU
The results add to 'current understanding of the role of different biomarkers in treatment response,' in this population, according to the lead study author.
Source: medscape.com
FDA Approves Pirtobrutinib for R/R Mantle Cell Lymphoma
This drug is the first BTK inhibitor approved to treat mantle cell lymphoma in this setting. Approval was based on overall response rates and duration of response in the phase 1/2 BRUIN trial.
Source: medscape.com
FDA OKs Zanubrutinib (Brukinsa) for CLL or SLL
The FDA granted accelerated approval to the BTK inhibitor zanubrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Source: medscape.com
Can 6 Minutes of Intense Cycling Put the Brakes on Alzheimer's?
Six minutes of high-intensity cycling increases production of a key protein that promotes neuroplasticity, learning, and memory ― which could help protect the aging brain, new research suggests.
Source: medscape.com